NDC 51079-539

Repaglinide

Repaglinide

Repaglinide is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Mylan Institutional Inc.. The primary component is Repaglinide.

Product ID51079-539_7d7c90ae-ab87-0bc2-e053-2991aa0a6602
NDC51079-539
Product TypeHuman Prescription Drug
Proprietary NameRepaglinide
Generic NameRepaglinide
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2014-02-27
Marketing End Date2019-03-31
Marketing CategoryANDA /
Application NumberANDA090252
Labeler NameMylan Institutional Inc.
Substance NameREPAGLINIDE
Active Ingredient Strength1 mg/1
Pharm ClassesGlinide [EPC],P
NDC Exclude FlagN

Packaging

NDC SPL Data Element Entries

NDC 51079-539-03 [51079053903]

Repaglinide TABLET
Marketing CategoryANDA
Application NumberANDA090252
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-02-27
Marketing End Date2019-03-31

NDC 51079-539-01 [51079053901]

Repaglinide TABLET
Marketing CategoryANDA
Application NumberANDA090252
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2014-02-27
Marketing End Date2019-03-31

Drug Details

Medicade Reported Pricing

51079053903 REPAGLINIDE 1 MG TABLET

Pricing Unit: EA | Drug Type:

51079053901 REPAGLINIDE 1 MG TABLET

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Repaglinide" or generic name "Repaglinide"

NDCBrand NameGeneric Name
0378-3122Repagliniderepaglinide
0378-3123Repagliniderepaglinide
0574-0240RepaglinideREPAGLINIDE
0574-0241RepaglinideREPAGLINIDE
0574-0242RepaglinideREPAGLINIDE
51079-539Repagliniderepaglinide
51991-853REPAGLINIDEREPAGLINIDE
51991-854REPAGLINIDEREPAGLINIDE
51991-855REPAGLINIDEREPAGLINIDE
57237-157RepaglinideRepaglinide
57237-158RepaglinideRepaglinide
57237-159RepaglinideRepaglinide
57664-745RepaglinideRepaglinide
57664-747RepaglinideRepaglinide
60429-484REPAGLINIDEREPAGLINIDE
60429-485REPAGLINIDEREPAGLINIDE
60429-486REPAGLINIDEREPAGLINIDE
68084-967RepaglinideRepaglinide
68084-954RepaglinideRepaglinide
65862-670RepaglinideRepaglinide
65862-671RepaglinideRepaglinide
65862-672RepaglinideRepaglinide
0169-0081Prandinrepaglinide
0169-0082Prandinrepaglinide
0169-0084Prandinrepaglinide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.